Related Experiment Video
Updated: Jul 3, 2026
12:11
A Rhodopsin Transport Assay by High-Content Imaging Analysis
Published on: January 16, 2019
IMP dehydrogenase-linked retinitis pigmentosa.
1Department of Chemistry, Brandeis University, Waltham, Massachusetts, USA. hedstrom@brandeis.edu
Nucleosides, Nucleotides & Nucleic Acids
|July 5, 2008
Summary
Mutations in inosine monophosphate dehydrogenase type 1 (IMPDH1) can cause retinal diseases by affecting its nucleic acid binding, not its enzymatic function. This highlights a new role for IMPDH1 in RNA metabolism vital for photoreceptor health.
Area of Science:
- Ophthalmology
- Molecular Biology
- Genetics
Background:
- Retinal diseases stem from mutations in photoreceptor-specific proteins.
- Some retinal diseases arise from mutations in broadly expressed proteins, such as inosine monophosphate dehydrogenase type 1 (IMPDH1).
- IMPDH1 is essential for guanine nucleotide biosynthesis and binds single-stranded nucleic acids.
Purpose of the Study:
- To investigate the role of IMPDH1 mutations in retinal disease pathogenesis.
- To determine the functional impact of pathogenic IMPDH1 mutations.
Main Methods:
- Analysis of IMPDH1 mutations.
- Assessment of IMPDH1 enzymatic activity.
- Evaluation of IMPDH1 single-stranded nucleic acid binding affinity and specificity.
Main Results:
- Pathogenic IMPDH1 mutations are located in or near the CBS domains.
- These mutations do not impair the enzymatic activity of IMPDH1.
- Mutations significantly reduce the affinity and specificity of IMPDH1 for single-stranded nucleic acids.
Conclusions:
- IMPDH1's role in RNA metabolism is critical for photoreceptor function.
- Altered nucleic acid binding, rather than impaired enzymatic activity, is the likely mechanism for IMPDH1-related retinal disease.
- IMPDH1 represents a potential therapeutic target for certain inherited retinal disorders.
